RxDoctor Payments Data

Bijayee Shrestha, PhD

Anatomic Pathology & Clinical Pathology · Mountain View, CANPI 1629268453

Payments from drug & device makers

$161in general payments, 2019–2025

Across 5 payments — averaging $32.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stemline Therapeutics Inc.$67
  • Seagen Inc.$33
  • Amgen$29
  • AstraZeneca$20
  • Foundation Medicine, Inc.$13

What the payments were for

  • Food & beverage$161100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$161 in reported general payments places this provider in the 50th percentile of 814 anatomic pathology & clinical pathology providers in California.

See all anatomic pathology & clinical pathology providers in California

Medicare billing

Part B allowed, 2024
$187,977
Medicare patients
712
Services billed
3,453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Mountain View

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →